Alcohol
Volume 24, Issue 2 , Pages 87-93 , June 2001

Neurobiological mechanisms of nicotine craving

  • Hisatsugu Miyata

      Affiliations

    • Department of Psychiatry, Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-ku, Tokyo 105-8461, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-3-3433-1111; fax: +81-3-3437-0228
    • ,
  • Tomoji Yanagita

      Affiliations

    • Department of Pharmacology I, Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-ku, Tokyo 105-8461, Japan

Received 19 September 2000 ,Revised 15 February 2001 ,Accepted 24 February 2001.

References 

  1. In:  Aggleton J editors. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York: Wiley-Liss; 1992;
  2. Altman J, Everitt BJ, Glautier S, Markou A, Nutt D, Oretti R, et al. The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology (Berl). 1996;125:285–345
  3. Andersson K, Fuxe K, Eneroth P, Jansson A, Harfstrand A. Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat. Naunyn Schmiedebergs Arch Pharmacol. 1989;339:387–396
  4. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Watkins GL, et al. Remembering the past: two facets of episodic memory explored with positron emission tomography. Am J Psychiatry. 1995;152:1576–1585
  5. Bindra D. Neuropsychological interpretation of the effects of drive and incentive motivation on general activity and instrumental behavior. Psychol Rev. 1968;75:1–22
  6. Bohus B, DeKloet ER, Veldhuis HD. Adrenal steroids and behavioral adaptation: relationship to brain corticoid receptors. In:  Ganten D,  Pfaff D editor. Current Topics in Neuroendocrinology. Heidelberg: Springer-Verlag; 1982;p. 107–148
  7. Bolles RC. Reinforcement, expectancy, and learning. Psychol Rev. 1972;79:394–409
  8. Burns LH, Robbins TW, Everitt BJ. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of d-amphetamine. Behav Brain Res. 1993;55:167–183
  9. Cador M, Robbins TW, Everitt BJ. Involvement of the amygdala in stimulus–reward associations: interaction with the ventral striatum. Neuroscience. 1989;30:77–86
  10. Cahill L, Babinsky R, Markowitsch HJ, McGaugh JL. The amygdala and emotional memory. Nature. 1995;377:295–296
  11. Cahill L, Prins B, Weber M, McGaugh JL. β-adrenergic activation and memory for emotional events. Nature. 1994;371:702–704
  12. Carr GD, Fibiger HC, Phillips AG. Conditioned place preference as a measure of drug reward. In:  Liebman JM,  Cooper SJ editor. The Neuropharmacological Basis of Reward. New York: Oxford University Press; 1989;p. 264–319
  13. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 1999;156:11–18
  14. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain. 1995;118:279–306
  15. DeWied D. Peptides and adaptive behaviour. In:  DeWied D,  Van Keep PA editor. Hormones and the Brain. Lancaster: MTP Press; 1980;p. 103–113
  16. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 1998;393:76–79
  17. Everitt BJ, Cador M, Robbins TW. Interactions between the amygdala and ventral striatum in stimulus–reward associations: studies using a second-order schedule of sexual reinforcement. Neuroscience. 1989;30:63–75
  18. Everitt BJ, Morris KA, O'Brien A, Robbins TW. The basolateral amygdala–ventral striatal system and conditioned place preference: further evidence of limbic–striatal interactions underlying reward-related processes. Neuroscience. 1991;42:1–18
  19. F10–F19 . Mental and behavioural disorders due to psychoactive substance use. In:  Cooper JE editors. Pocket Guide to the ICD–10 Classification of Mental and Behavioural Disorders: with Glossary and Diagnostic Criteria for Research—ICD–10:DCR–10. Edinburgh: Churchill Livingstone; 1994;p. 63–91
  20. Fiez JA. Cerebellar contributions to cognition. Neuron. 1996;16:13–15
  21. Fuxe K, Agnati LF, Jansson A, von Euler G, Tanganelli S, Andersson K, et al. Regulation of endocrine function by the nicotinic cholinergic receptor. In:  Bock G,  Marsh J editor. The Biology of Nicotine Dependence. Chichester: John Wiley & Sons; 1990;p. 113–130
  22. Gaffan D, Harrison S. Amygdalectomy and disconnection in visual learning for auditory secondary reinforcement by monkeys. J Neurosci. 1987;7:2285–2292
  23. Gallagher M, Holland PC. The amygdala complex: multiple roles in associative learning and attention. Proc Natl Acad Sci USA. 1994;91:11771–11776
  24. Gao J-H, Parsons LM, Bower JM, Xiong J, Li J, Fox PT. Cerebellum implicated in sensory acquisition and discrimination rather than motor control. Science. 1996;272:545–547
  25. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry. 1986;43:107–113
  26. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264:1546–1549
  27. Goldberg SR, Spealman RD, Goldberg DM. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science. 1981;214:573–575
  28. Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA. 1996;93:12040–12045
  29. Grenhoff J, Aston-Jones G, Svensson TH. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand. 1986;128:351–358
  30. Henningfield JE, Johnson RE, Jasinski DR. Clinical procedures for the assessment of abuse potential. In:  Bozarth MA editors. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag; 1987;p. 573–590
  31. Hiroi N, White NM. The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J Neurosci. 1991;11:2107–2116
  32. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43:289–294
  33. Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A. Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl). 1984;83:82–87
  34. Iwamoto ET. Nicotine conditions place preferences after intracerebral administration in rats. Psychopharmacology (Berl). 1990;100:251–257
  35. Jaffe JH. Drug addiction and drug abuse. In:  Gilman AG,  Rall TW,  Nies AS,  Taylor P editor. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: Pergamon; 1990;p. 522–573
  36. Jaffe JH. Tobacco smoking and nicotine dependence. In:  Wonnacott S,  Russell MAH,  Stolerman IP editor. Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. Oxford: Oxford Science Publications; 1990;p. 1–37
  37. Jasinski DR, Johnson RE, Kocher TR. Clonidine in morphine withdrawal. Differential effects on signs and symptoms. Arch Gen Psychiatry. 1985;42:1063–1066
  38. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science. 1988;242:715–723
  39. LeDoux JE. Emotional memory systems in the brain. Behav Brain Res. 1993;58:69–79
  40. Lett BT. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl). 1989;98:357–362
  41. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, et al. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry. 1998;155:124–126
  42. Markou A, Koob GF. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology. 1991;4:17–26
  43. Markou A, Weiss F, Gold LH, Caine B, Schulteis G, Koob GF. Animal models of drug craving. Psychopharmacology (Berl). 1993;112:163–182
  44. Meil WM, See RF. Excitotoxic lesions of the basolateral amygdala attenuate the ability of drug-associated cues to reinstate responding during the withdrawal from self-administration. Soc Neurosci. 1995;21:767.17
  45. Middleton FA, Strick PL. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science. 1994;266:458–461
  46. Mogenson GJ, Jones DL, Yim CY. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol. 1980;14:69–97
  47. Museo E, Wise RA. Place preference conditioning with ventral tegmental injections of cytisine. Life Sci. 1994;55:1179–1186
  48. O'Brien CP, Childress AR, McLellan AT, Ehrman R. A learning model of addiction. In:  O'Brien CP,  Jaffe J editor. Advances in Understanding the Addictive States. New York: Raven Press; 1992;p. 157–177
  49. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev Brain Res. 1993;18:247–291
  50. Schmahmann JD, Pandya DN. Prefrontal cortex projections to the basilar pons in rhesus monkey: implications for the cerebellar contribution to higher function. Neurosci Lett. 1995;199:175–178
  51. Schuckit, M. A., Helzer, J. E., Cottler, L. B., Crowley, T., Nathan, P. E., & Woody, G. E. (DSM–IV Work Group). (1994). Substance-related disorders. In American Psychiatric Association, (A. Frances, H.A. Pincus, M.B. First [Task Force on DSM–IV]), Diagnostic and Statistical Manual of Mental Disorders (4th ed.) (pp. 175–272). Washington, DC: American Psychiatric Association
  52. Schulteis G, Markou A, Cole M, Koob GF. Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA. 1995;92:5880–5884
  53. Schulteis G, Markou A, Gold LH, Stinus L, Koob GF. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther. 1994;271:1391–1398
  54. Shippenberg TS, Heidbreder CH. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther. 1995;273:808–815
  55. Solomon RL. An opponent-process theory of motivation. IV. The affective dynamics of addiction. In:  Maser JD,  Seligman MEP editor. Psychopathology: Experimental Models. San Francisco: Freeman; 1977;
  56. Solomon RL, Corbit JD. An opponent-process theory of motivation. II. Cigarette addiction. J Abnorm Psychol. 1973;81:158–171
  57. Solomon RL, Corbit JD. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev. 1974;81:119–145
  58. Spealman RD, Goldberg SR. Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol. 1978;18:313–339
  59. Squire LR, Knowlton BJ. Memory, hippocampus, and brain systems. In:  Gazzaniga MS editors. The Cognitive Neurosciences. Cambridge: MIT Press; 1995;p. 825–837
  60. Stinus L, Le Moal M, Koob GF. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience. 1990;37:767–773
  61. Stolerman I. Drugs of abuse: behavioural principles, methods and terms. Trends Pharmacol Sci. 1992;13:170–176
  62. Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive. Psychopharmacology (Berl). 1995;117:2–10
  63. Suzuki T, Ise Y, Tsuda M, Maeda J, Misawa M. Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol. 1996;314:281–284
  64. Svensson TH, Grenhoff J, Engberg G. Effect of nicotine on dynamic function of brain catecholamine neurons. In:  Bock G,  Marsh J editor. The Biology of Nicotine Dependence. Chichester: John Wiley & Sons; 1990;p. 169–185
  65. Swedberg MDB, Henningfield JE, Goldberg SR. Nicotine dependency: animal studies. In:  Wonnacott S,  Russell MAH,  Stolerman IP editor. Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. Oxford: Oxford Science Publications; 1990;p. 38–76
  66. UNDCP and WHO Informal Expert Committee on the Drug-Craving Mechanism. Report. (1992). United Nations International Drug Control Programme and World Health Organization. Technical report series (No.V. 92-54439 T).
  67. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex. 1992;2:435–443
  68. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 1991;148:621–626
  69. West R, Hajek P. What happens to anxiety levels on giving up smoking?. Am J Psychiatry. 1997;154:1589–1592
  70. West RJ, Jarvis MJ, Russell MA, Carruthers ME, Feyerabend C. Effect of nicotine replacement on the cigarette withdrawal syndrome. Br J Addict. 1984;79:215–219
  71. Whitelaw RB, Markou A, Robbins TW, Everitt BJ. Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology (Berl). 1996;127:213–224
  72. Wise RA. The role of reward pathways in the development of drug dependence. Pharmacol Ther. 1987;35:227–263
  73. Wise RA. The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol. 1988;97:118–132
  74. Wonnacott S, Drasdo A, Sanderson E, Rowell P. Presynaptic nicotinic receptors and the modulation of transmitter release. In:  Bock G,  Marsh J editor. The Biology of Nicotine Dependence. Chichester: John Wiley & Sons; 1990;p. 87–112
  75. Yim CY, Mogenson GJ. Accumbens dopamine modulates amygdala suppression of spontaneous exploratory activity in rats. Soc Neurosci Abstr. 1987;2:830

PII: S0741-8329(01)00144-6

Alcohol
Volume 24, Issue 2 , Pages 87-93 , June 2001

Article Tools